Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015; 25; 716-759.

Article  PubMed  PubMed Central  Google Scholar 

Lebbink CA, Links TP, Czarniecka A, et al. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 2022; 11.

Google Scholar 

Gui Y, Huang D, Hou Y, et al. Predictive Factors for Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents. Front Oncol 2022; 12; 833775.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Paulson VA, Rudzinski ER, Hawkins DS. Thyroid Cancer in the Pediatric Population. Genes (Basel) 2019; 10; 723.

Article  PubMed  CAS  Google Scholar 

Lee YA, Lee H, Im SW, et al. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake. J Clin Invest 2021; 131; e144847.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Golpanian S, Perez EA, Tashiro J, et al. Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int 2016; 32; 201-208.

Article  PubMed  Google Scholar 

Stenman A, Backman S, Johansson K, et al. Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma. Endocr Relat Cancer 2021; 28; 337-351.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Franco AT, Ricarte-Filho JC, Isaza A, et al. Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers. J Clin Oncol 2022; 40; 1081-1090.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159; 676-690.

Article  Google Scholar 

Liang J, Cai W, Feng D, et al. Genetic landscape of papillary thyroid carcinoma in the Chinese population. J Pathol 2018; 244; 215-226.

Article  PubMed  CAS  Google Scholar 

Onder S, Mete O, Yilmaz I, et al. DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection. Endocr Pathol 2022; 33; 437-445.

Article  PubMed  CAS  Google Scholar 

Tang H, Bao H, Liu R, et al. Robust profiling of cancer-related gene fusions: Analytical validation of PANCARNA for multiple cancer types. Cancer Res 2024; 84; 7408-7408.

Article  Google Scholar 

Gudernova I, Foldynova-Trantirkova S, Ghannamova BE, et al. One reporter for in-cell activity profiling of majority of protein kinase oncogenes. Elife 2017; 6; e21536.

Article  PubMed  PubMed Central  Google Scholar 

Iyama K, Matsuse M, Mitsutake N, et al. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima. Thyroid 2017; 27; 811-818.

Article  PubMed  CAS  Google Scholar 

Bulanova Pekova B, Sykorova V, Mastnikova K, et al. RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis. Endocr Relat Cancer 2023; 30; e230117.

Article  PubMed  PubMed Central  Google Scholar 

Nakata T, Kitamura Y, Shimizu K, et al. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. Genes Chromosomes Cancer 1999; 25; 97-103.

Article  PubMed  CAS  Google Scholar 

Nakata T, Yokota T, Emi M, Minami S. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma. Genes Chromosomes Cancer 2002; 35; 30-37.

Article  PubMed  CAS  Google Scholar 

Chu YH, Wirth LJ, Farahani AA, et al. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. Mod Pathol 2020; 33; 2458-2472.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou L, Li J, Zhang X, et al. An integrative pan cancer analysis of RET aberrations and their potential clinical implications. Sci Rep 2022; 12; 13913.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Toda S, Yamamoto Y, Ookubo Y, et al. Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report. Gland Surg 2023; 12; 1441-1448.

Article  PubMed  PubMed Central  Google Scholar 

Ju G, Sun Y, Wang H, et al. Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer. J Clin Endocrinol Metab 2023; 109; 505-515.

Article  PubMed Central  Google Scholar 

Ibrahimpasic T, Xu B, Landa I, et al. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clin Cancer Res 2017; 23; 5970-5980.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Park SJ, Kang YE, Kim JH, et al. Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence. Clin Exp Otorhinolaryngol 2022; 15; 183-193.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chiosea S, Hodak SP, Yip L, et al. Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management. J Clin Endocrinol Metab 2023; 108; 2999-3008.

Article  PubMed  PubMed Central  Google Scholar 

Wu S, Liu Y, Li K, Liang Z, Zeng X. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid Cancer. J Mol Diagn 2023; 25; 569-582.

Article  PubMed  CAS  Google Scholar 

Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun 2014; 5; 4846.

Article  PubMed  CAS  Google Scholar 

Vanden Borre P, Schrock AB, Anderson PM, et al. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist 2017; 22; 255-263.

PubMed  CAS  Google Scholar 

Murugan AK, Qasem E, Al‑Hindi H, Alzahrani AS. Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers. Mol Clin Oncol 2021; 15; 210.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ritterhouse LL, Wirth LJ, Randolph GW, et al. ROS1 Rearrangement in Thyroid Cancer. Thyroid 2016; 26; 794-797.

Article  PubMed  CAS  Google Scholar 

Ritterhouse L, Dias-Santagata D, Nardi V, et al. The landscape of clinically actionable ALK/MET/RET/ROS1 fusions to reveal a shared pattern of protein domains in fusion partners. J Clin Oncol 2016; 34; 11560.

Article  Google Scholar 

Liu SV, Macke LA, Colton BS, et al. Response to Entrectinib in Differentiated Thyroid Cancer With a ROS1 Fusion. JCO Precis Oncol 2017; 1; PO.17.00105.

PubMed  PubMed Central  Google Scholar 

Hess JR, Newbern DK, Beebe KL, Walsh AM, Schafernak KT. High Prevalence of Gene Fusions and Copy Number Alterations in Pediatric Radiation Therapy-Induced Papillary and Follicular Thyroid Carcinomas. Thyroid 2022; 32; 411-420.

Article  PubMed